Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Blood-based protein biomarkers in bladder urothelial tumors
Rubén López-Cortés, Benito Blanco Gómez, Sergio Vázquez‐Estévez, et al.
Journal of Proteomics (2021) Vol. 247, pp. 104329-104329
Closed Access | Times Cited: 13

Showing 13 citing articles:

Clinical applications of plasma proteomics and peptidomics: Towards precision medicine
Bo He, Zhao Huang, Canhua Huang, et al.
PROTEOMICS - CLINICAL APPLICATIONS (2022) Vol. 16, Iss. 6
Closed Access | Times Cited: 40
Mini-Review: Current Bladder Cancer Treatment—The Need for Improvement
Emily Gill, Claire M. Perks
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1557-1557
Open Access | Times Cited: 11
Current look at the most promising proteomic and glycomic biomarkers of bladder cancer
Stefan Harsanyi, Kristína Kianičková, Jaroslav Katrlı́k, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 2
Open Access | Times Cited: 4
Targeted therapies in bladder cancer: signaling pathways, applications, and challenges
Mei Peng, Xuetong Chu, Yan Peng, et al.
MedComm (2023) Vol. 4, Iss. 6
Open Access | Times Cited: 7
Analysis of carbohydrates and glycoconjugates by matrix‐assisted laser desorption/ionization mass spectrometry: An update for 2021–2022
David J. Harvey
Mass Spectrometry Reviews (2024)
Open Access | Times Cited: 2
Bladder cancer biomarkers: current approaches and future directions
Melika Ahangar, Frouzandeh Mahjoubi, Seyed Javad Mowla
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Label-free LC-MS/MS proteomics analyses reveal CLIC1 as a predictive biomarker for bladder cancer staging and prognosis
Weifeng Wang, Guankai Huang, Hansen Lin, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 6
Hsa_circ_0003221 facilitates the malignant development of bladder cancer cells via resulting in the upregulation of DHCR24 by targeting miR-892b
Peng Lu, Yingchun Jiang, Zongyu Xia
Investigative and Clinical Urology (2022) Vol. 63, Iss. 5, pp. 577-577
Open Access | Times Cited: 9
Proteomics as a Complementary Technique to Characterize Bladder Cancer
Rubén López-Cortés, Sergio Vázquez‐Estévez, Javier Álvarez Fernández, et al.
Cancers (2021) Vol. 13, Iss. 21, pp. 5537-5537
Open Access | Times Cited: 11
Golgi signalling proteins GOLPH3, MYO18A, PITPNC1 and RAB1B: implications in prognosis and survival outcomes of AML patients
Yomna O. Ali, Sara M. Radwan, Alia Saeed, et al.
Biomarkers (2023) Vol. 28, Iss. 4, pp. 387-395
Closed Access | Times Cited: 4
Discovery of Notch Pathway-Related Genes for Predicting Prognosis and Tumor Microenvironment Status in Bladder Cancer
Xianchao Sun, Shiyong Xin, Weiyi Li, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 7
Advances in Liquid Biopsy for Diagnosis of Bladder Cancer
Jaekwon Seok, Yeonjoo Kwak, Sewhan Kim, et al.
International Neurourology Journal (2024) Vol. 28, Iss. 2, pp. 83-95
Open Access | Times Cited: 1
Biochemical and molecular study of extracellular MiR-21-5p and MiR-99-5p as diagnostic biomarkers of urothelial bladder carcinoma
Mohamed S. Rizk, Sally M. El‐Hefnawy, Sultan M. Sultan, et al.
Gene Reports (2023) Vol. 32, pp. 101793-101793
Closed Access | Times Cited: 1
Page 1

Scroll to top